ArticleACS medicinal chemistry letters2021

Novel Heteroaromatic Carboxamides as Plasma Kallikrein Inhibitors for Treating Diabetic Complications, Ocular Diseases, and Edema-Associated Diseases.

No numbers read from the abstract.

Not cited yet